Kataoka, N.; Kunimatsu, Y.; Tsutsumi, R.; Tani, N.; Sato, I.; Tanimura, M.; Nakano, T.; Tanimura, K.; Kato, D.; Takeda, T.
Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report. Medicina 2021, 57, 547.
https://doi.org/10.3390/medicina57060547
AMA Style
Kataoka N, Kunimatsu Y, Tsutsumi R, Tani N, Sato I, Tanimura M, Nakano T, Tanimura K, Kato D, Takeda T.
Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report. Medicina. 2021; 57(6):547.
https://doi.org/10.3390/medicina57060547
Chicago/Turabian Style
Kataoka, Nobutaka, Yusuke Kunimatsu, Rei Tsutsumi, Nozomi Tani, Izumi Sato, Mai Tanimura, Takayuki Nakano, Keiko Tanimura, Daishiro Kato, and Takayuki Takeda.
2021. "Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report" Medicina 57, no. 6: 547.
https://doi.org/10.3390/medicina57060547
APA Style
Kataoka, N., Kunimatsu, Y., Tsutsumi, R., Tani, N., Sato, I., Tanimura, M., Nakano, T., Tanimura, K., Kato, D., & Takeda, T.
(2021). Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report. Medicina, 57(6), 547.
https://doi.org/10.3390/medicina57060547
